Hi all. I have been looking at the performance shares ~ 217 million which expire in June 2021.
The reason I was looking is these shares are pretty much hitched to lung cancer and for them to vest they need to have completed a 2000 person study with certain sensitivity and specificity being attained.
Whilst 2 years sounds like a long time away a 2000 person trial will take a power of time to organise.
So my question is.
When are they likely to start work on this?
My take is they will do something on this sooner rather than later. At current sp Dr Finger has ~ $3.8 million at stake
Or is it already too late.....is 2 years too little time for a 2000 person study?
The hurdles and performance share break down below.
Performance Shares
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.5¢ |
Change
0.020(3.54%) |
Mkt cap ! $64.51M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 58.5¢ | 56.5¢ | $3.293K | 5.744K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.5¢ | 8303 | 1 |
View Market Depth
| Last trade - 12.53pm 09/08/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |